Myocardial Protection by Lidoflazine during One--Hour Normothermic Global Ischemia

Daenen, W.; Flameng, W.
August 1981
Angiology;Aug1981, Vol. 32 Issue 8, p543
Academic Journal
The cardioprotective effects of lidoflazine, a drug with calcium homeostatic properties, were studied in 12 dogs (6 drug-treated and 6 controls) subjected to 1-hour normothermic global ischemia. None of the control dogs could be weaned from the extracorporeal bypass after 30 minutes of reperfusion. In contrast, all acutely pre-treated animals were able to support their own circulation. Recovery of pre-ischemic values in this group was 97 ± 3% for systolic aortic pressure, 69 ± 7% for diastolic aortic pressure, 97 ± 10% for left ventricular pressure, and 84 ± 11% for cardiac output. Electron microscopy and calcium cytochemistry were done on left ventricular biopsies taken before, during, and after ischemic arrest. In the control group, severe damage to the sarcolemma and the mitochondria was found at the end of the ischemic period and became more prominent after 5 and 30 minutes of reperfusion. There was great accumulation of calcium in the damaged mitochondria. In the lidoflazine-treated dogs, these lesions were largely prevented. These findings suggest a strong cardioprotective effect of lidoflazine during severe myocardial ischemia.


Related Articles

  • Measurement of Physical Changes in the Myocardium for Development of Novel Methods for Diagnosing Ischemia. Munir, M. S.; Shankar, K. J.; Payvar, Saeed; Eftekhari, Hossein; Brewer, Alan; Robertson, Jillian; Stupin, Igor V.; Sobash, Ed; Casscells, S. Ward; Ahmed, Amany // Current Cardiology Reviews;2007, Vol. 3 Issue 4, p274 

    The purpose of this review is to offer a concise discussion of existing data describing changes in the physical properties of the myocardium in response to ischemia. We argue that these measurable changes may be used as a basis for the development of newer diagnostic methods. Because of the...

  • Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation. Vöhringer, Matthias; Flewitt, Jacqueline A.; Green, Jordin D.; Dharmakumar, Rohan; Jiun Wang; Tyberg, John V.; Friedrich, Matthias G. // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2010, Vol. 12, p20 

    Background: As myocardial oxygenation may serve as a marker for ischemia and microvascular dysfunction, it could be clinically useful to have a non-invasive measure of changes in myocardial oxygenation. However, the impact of induced blood flow changes on oxygenation is not well understood. We...

  • Effects of Buflomedil on Erythrocyte Deformability. Dormandy, J. A.; Ernst, E. // Angiology;Oct1981, Vol. 32 Issue 10, p714 

    This brief communication outlines recent experiments on the effects of buflomedil, a new vasoactive agent, on red cell deformability in patients with leg ischemia. In this randomized, double-blind cross-over study, 10 patients received 200 mg buflomedil and matching placebo intravenously. Red...

  • Beneficial Effect of Papaverine Plus Raubasine in Peripheral Arterial Insufficiency. Brevetti, Gregorio; Chiariello, Massimo; Verrienti, Salvatore; Spena, Michele; Desiderati, Maurizio; Condorelli, Mario // Angiology;Aug1983, Vol. 34 Issue 8, p517 

    It has been demonstrated that, in most arteriopathic patients, vasodilators induce the vascular steal phenomenon, i.e. the shunting of blood from the ischemic to the normally perfused areas. It is conceivable, therefore, that vasoconstrictors may improve in the opposite way, reducing the blood...

  • Ethanol and Hypertrophic Cardiomyopathy. Paz, Rami; Tunick, Paul A.; Kronzon, Itzhak // New England Journal of Medicine;3/20/97, Vol. 336 Issue 12, p878 

    A response by Rami Paz, Paul A. Tunick, and Itzhak Kronzon to a letter to the editor about their article "Ethanol and Hypertrophic Cardiomyopathy," which was published in the September 26, 1996 issue, is presented.

  • Neovascularization of lschemic Myocardium by Newly Isolated Tannins Prevents Cardiomyocyte Apoptosis and Improves Cardiac Function. Xuemei Gu; Lei Cheng; Winghong L. Chueng; Xinsheng Yao; Hon Gwei Liu; Guoqing Qi; Ming Li // Molecular Medicine;Nov/Dec2006, Vol. 12 Issue 11/12, p275 

    During remodeling progress post myocardial infarction, the contribution of neoangiogenesis to the infarct-bed capillary is insufficient to support the greater demands of the hypertrophied but viable myocardium resulting in further ischemic injury to the viable cardiomyocytes at risk. Here we...

  • An Overview of the Pharmacology and Pharmacokinetics of Nicardipine. Whiting, R. L.; Dow, R. J.; Graham, D. J. M.; Mroszczak, E. J. // Angiology;Nov1990 Part 2, Vol. 41, p987 

    The article presents an overview of the pharmacology and pharmacokinetics of Nicardipine. Nicardipine is an antagonist of the L-type Calcium ion channel, which demonstrates greater potency against vascular smooth muscle than for cardiac muscle. This profile is indicative of a compound that will...

  • Calcium Antagonists: Pharmacologic Agents in Search of New Clinical Indications. Gasser, Robert // Angiology;Jan1990, Vol. 41 Issue 1, p36 

    The broad availability of new pharmacologic agents is usually followed by both the search for similar compounds with more specific and refund actions and the expansion of clinical applicability for these agents. During the last twenty years extensive investigations have revealed that calcium...

  • Ratiometric imaging of calcium during ischemia-reperfusion injury in isolated mouse hearts using Fura-2. Venkataraman, Raghav; Holcomb, Mark R.; Harder, Rene; Knollmann, Bj�rn C.; Baudenbacher, Franz // BioMedical Engineering OnLine;2012, Vol. 11 Issue 1, p39 

    Background: We present an easily implementable method for measuring Fura-2 fluorescence from isolated mouse hearts using a commercially available switching light source and CCD camera. After calibration, it provides a good estimate of intracellular [Ca2+] with both high spatial and temporal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics